|
Market Cap (10-Jun) $47,863,656 (0th) |
Close (30-Jun) $0.85 |
Volume (30-Jun) 942,590 |
Shortsold (27-Oct) 800,001 (0.58%) (257th) |
|
52w High $0.490 |
52w Low $0.312 |
P/E - |
EPS -0.06 |
IIQ released this announcement to the ASX on 28 September 2022, 9:20. The announcement is marked as price sensitive, and is 80 page(s) in length and 1.92MB in size.
You can view all announcements from IIQ and see how they appear on a price chart on the announcements page.
At the date of this announcement, IIQ was 0.002% short sold according to ASIC data. It was ranked the 630th most shorted stock on the ASX. It is now ranked as the 257th most shorted stock on the ASX with 0.576% of total shares short sold as of the latest reported data (27 October 2025).
| Other Recent Announcements from IIQ | |
|---|---|
| Notification of cessation of securities - IIQ | 30 June 2023, 14:19 |
| SubB2M/CA15.3 Clinical Validation Data Investor Presentation | 29 June 2023, 10:48 |
| INOVIQ Investor Briefing | 27 June 2023, 14:07 |
| 2022 Annual Report and update on results | 28 September 2022, 9:20 |
| Appendix 4E and Preliminary Financial Report | 30 August 2022, 18:42 |
| IIQ Investor Presentation | 9 August 2022, 10:18 |
| INOVIQ Investor Briefing Invitation - June 2022 Quarter | 4 August 2022, 10:00 |
You must be logged in to post a reply.
